Mode
Text Size
Log in / Sign up

insulin glulisine

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of insulin glulisine

13 trials tracked of insulin glulisine: 8 in phase 3 or 4 and 1 with published results. The most-cited published study has 47 citations.

13Trials tracked
8Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 8 Phase 2 3 Phase 1 2
  1. Phase 4 Glargine U300 Hospital Trial Completed · 47 cited
  2. Phase 4 The Effect of Insulin Glulisine Compared With Insulin Aspart on Breakfast Post Prandial Glucose Levels in Prepubertal Children Completed
  3. Phase 4 CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM) Completed
  4. Phase 4 Effect of Insulin Glulisine Compared to Insulin Aspart and Insulin Lispro When Administered by Continuous Subcutaneous Insulin Infusion (CSII) on Specific Pump Parameters in Patient With Type 1 Diabetes Mellitus Completed
  5. Phase 4 Basal Bolus Insulin Versus SSRI in Type 2 Diabetes Undergoing General Surgery Completed
  6. Phase 4 Diabetes in the Elderly: Prospective Study Completed
Show 7 more trials
  1. Phase 4 Insulin Glulisine in Type 2 Diabetic Patients Completed
  2. Phase 4 Insulin Glargine "All to Target" Trial Completed
  3. Phase 2 Safety and Effectiveness Study of Intranasal Insulin Glulisine on Cognitive and Memory in Mild-Mod AD Patients. Completed
  4. Phase 2 Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus Completed
  5. Phase 2 Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 2 Diabetes Mellitus Completed
  6. Phase 1 A Pharmacokinetic and Glucodynamic Study of Subcutaneously Administered Insulin Analogs With rHuPH20 Compared to Insulin Analogs Alone Completed
  7. Phase 1 Investigation of the Safety of Intranasal Glulisine in Down Syndrome Completed

Showing the 13 most-cited and recently-updated of 13 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.